Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients.
Tranquil Clinical Research successfully completed a Phase II clinical trial in COVID patients as the CRO conducting all clinical trial operations including: Protocol development, FDA submissions/approvals, pharmacovigilance, clinical project management, clinical operations and with the highest level of quality deliverables throughout the entirety of the study lifecycle.